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A need exists for rapid, low-cost, and accurate infectious viral quantification method in the bio-pharmaceutical
field for the production of vaccines and virus-based therapeutics. Two of the most common and traditionally
employed methods to quantify infectious viruses are plaque assays and cell culture infectious dose 50 (CCID 50);
both are relatively inexpensive, however they can be time consuming and demonstrate significant variability
between operators. Here we present a method to quantify infectious viruses using the post-infection granular
changes within the cell using flow cytometry to create a more rapid and high throughput quantification method. To
validate this method, a recombinant Vero cell line was infected with a replication-deficient herpes simplex virus
type 2 mutant and monitored over a 72 hour period for changes in granularity, using flow cytometry. Between 1620 hours post infection (hpi), the percentage of the cell population displaying a high degree of granularity can be
logarithmically correlated to the infectious titer of the viral sample. The granularity-based assay was used to
estimate the infectious titer of 5 separate virus samples and the results were compared titers obtained through
plaque assays. It was found that there was a maximum difference of 52.67% in the average titers between assays.
To further demonstrate this as a universal method, Japanese quail muscle fibroblast cells (QT-35) were infected
with a highly attenuated canarypox virus and their granularity was tracked. A similar increase in granularity post
infection was detected, thereby giving credence to the utility of this viral enumeration technique across a potentially
broad virus-host cell range. Given the high level of correlation between the proposed and traditional methods of
viral quantification, the use of flow cytometry could aid in process development and optimization by decreasing
the time required to assess the affect of production conditions on viral products.

Figure 1- Semilogarithmic plot correlating the percent of
the population with high granularity to the concentration
of infective virus (PFU) for 6 separate herpes virus
samples. The trend line was calibrated using a standard
sample with a well-defined titer
Table 1- A comparison of the infectious titers obtained
from each assay with the variance associated with each
measurement. The difference between the two assays
was calculated by: (Mean titer of Granularity-based
assay – Mean titer of Plaque assay) / (Mean titer of
Plaque assay) x 100

Sample

A
B
C
D
E

Plaque
Assay
(106)
6.00±1.81
6.33±4.13
6.34±2.20
6.28±0.99
61.7±7.67

Coefficient
of Variance
30.11%
65.35%
34.62%
15.81%
12.43%

Granularitybased flow
assay (106)
9.16±4.53
8.94±3.00
4.13±1.33
4.96±1.50
90.3±39.1

Coefficient
of Variance
49.42%
33.52%
32.17%
30.23%
43.26%

Difference
between
assays
-52.67%
-41.32%
34.85%
21.01%
-46.45%

